With its platform, XO Life aims to enable patients to To record patient-reported outcomes (PRO) in a standardized and data protection-compliant mannerThese summarize patients' own experiences with their health status, medications, and illnesses. This allows them to be compared with other users and made available to the healthcare industry in an anonymized form.
The patient perspective is increasingly being incorporated, particularly in the development of individualized treatments within the framework of precision medicine, but also in the evaluation of patient benefits from a reimbursement perspective. Therefore, XO Life aims to make the recording of patient experiences on its platform a standard in healthcare. To this end, the Startup with headquarters in Munich, works with one of the leading European research institutes for patient-centered research, the Promis Institute Germany of the Charité, as well as various pharmaceutical manufacturers.
XO Life is funded by the medtech industry
The €2 million financing round is therefore being primarily funded by players from the medtech sector: the international healthcare VC Seedlink, the corporate VC Mediventures of the pharmaceutical company Medice, Aescuvest, a fintech company focused on financing digital startups in the healthcare sector, and other healthcare technology service providers. The fresh funds will now primarily be used to expand the platform's product and development capacities.
Friderike Bruchman, Co-Founder & CEO of XO Life, explains:
"We are excited to continue expanding our partner network with our new, expert partners from the healthcare sector. With our platform, we are setting a standard for directly capturing patient insights in real-life care settings and enabling every patient and all healthcare stakeholders to participate."
And Tim Jürgens, Partner at Seedlink, added:
"We looked at many startups in the field of real-world evidence and user engagement, and XO Life's platform approach to covering many different indications is particularly compelling. With its public platform, XO Life, in cooperation with the Charité Research Institute, is setting a standard for collecting patient feedback for all therapies. Pharmaceutical and medtech manufacturers can also use the platform for product-specific patient insights."
